Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.85M | 5.52M | 8.49M | 6.86M | 22.89M | Gross Profit |
4.32M | 3.22M | 4.85M | 3.87M | 13.49M | EBIT |
-9.48M | -10.11M | -12.09M | -18.78M | -24.58M | EBITDA |
-9.27M | -6.47M | -10.93M | -19.97M | -43.13M | Net Income Common Stockholders |
-12.78M | -9.03M | -13.78M | -21.49M | -41.48M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
13.59M | 22.99M | 11.82M | 15.30M | 39.60M | Total Assets |
14.88M | 24.16M | 35.41M | 43.95M | 82.34M | Total Debt |
17.35M | 14.97M | 18.70M | 23.05M | 39.65M | Net Debt |
3.76M | -8.03M | 6.88M | 7.75M | 1.51M | Total Liabilities |
28.80M | 26.28M | 30.76M | 35.13M | 50.75M | Stockholders Equity |
-12.27M | -2.48M | 5.80M | 9.40M | 35.53M |
Cash Flow | Free Cash Flow | |||
-8.21M | -2.70M | -8.53M | -13.01M | -38.49M | Operating Cash Flow |
-8.20M | -2.57M | -8.52M | -13.01M | -36.39M | Investing Cash Flow |
213.00K | 14.78M | 3.41M | 1.45M | 17.88M | Financing Cash Flow |
-1.34M | -766.00K | 1.31M | -11.94M | -3.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
60 Neutral | $13.88B | 7.03 | -2.76% | 3.71% | 2.20% | -43.04% | |
50 Neutral | HK$49.66M | ― | -12.59% | ― | -6.14% | -23.09% | |
45 Neutral | HK$55.42M | ― | 0.35% | ― | -7.08% | -199.00% | |
38 Underperform | HK$91.80M | ― | -24.92% | ― | 18.07% | -492.42% | |
35 Underperform | HK$354.12M | ― | ― | -23.18% | -117.81% | ||
21 Underperform | HK$23.69M | ― | ― | 16.32% | 57.06% |